Medicare Will Test Payment Model For Accelerated Approvals To ‘Expedite’ Confirmatory Trials

The Center for Medicare and Medicaid Innovation also will develop demonstrations focused on payment arrangements for cell and gene therapy in Medicaid and promoting generic drugs in Medicare Part D.

CMMI is planning a Big Expansion Of Work In the drug pricing area. • Source: Shutterstock

An ambitious new Centers for Medicare and Medicaid Innovation plan will test three new payment models aimed at lowering drug costs and increasing treatment access involving: 

Announced 14 February, the CMMI demonstrations were developed in response to an executive order issued by President Biden last fall....

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Market Access

More from Pink Sheet